Company / Profit Margin
Immuneering Corp Profit Margin History
FY2021-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-15937.3%
FY2023
5-year range
-15937.3% / -737.2%
FY2021-FY2023
Trend
-888.5%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Profit Margin changed -888% YoY in FY2023, a notable deviation from the 2-year average annual change of -504%.
Based on SEC 10-K filings.
-15937.3% in FY2023.
Declined from -737.2% to -15937.3% over the past 2 years.
Profit Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2023, profit margin decreased 888.5% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -7.35 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2023 | -15937.3% | -888.5% |
| FY2022 | -1612.3% | -118.7% |
| FY2021 | -737.2% | - |
As of FY2023 · SEC 10-K · Updated Jun 24, 2026